Safe Supply enters manufacturing deal with MobileDetect

Executive Summary

• Safe Supply Streaming Co. Ltd. entered a 12‑month manufacturing and supply agreement with MobileDetect Bio Inc. (MDBio) to produce 200,000 custom ToxiShield test‑kit units in the United States.
• The partnership aligns with recent U.S. HHS funding of >$1.5 billion for State and Tribal Opioid Response programs, positioning the products for distribution to communities, universities, non‑profits and public agencies receiving grant support.
• Each ToxiShield unit contains five rapid fentanyl/drink‑spiking test kits, pre‑measured buffer solution, sampling tools and QR‑linked instructions, manufactured at MDBio’s Sugar Land, Texas facility.

Key Details

• Agreement term: 12 months, commencing immediately.
• Quantity: Up to 200,000 ToxiShield units (each unit = 5 test kits).
• Manufacturing location: MDBio facility, Sugar Land, Texas, USA.
• Product description: Rapid, discreet test kits for detecting fentanyl, drink‑spiking and other harmful substances; includes buffer solution, sampling tools, QR‑linked usage instructions.
• Strategic rationale: Enables domestic production to meet urgent public‑health demand tied to HHS State Opioid Response (SOR) and Tribal Opioid Response (TOR) grant programs.
• Funding context: U.S. HHS announced on Sept. 22 a continuation of $1.48 billion for SOR and $63 million for TOR, earmarked for overdose prevention, treatment and recovery supports.
• Executive comments:
• Geoff Benic (CEO, Safe Supply) – “This agreement provides a critical foundation for scaling our public health response in the U.S.”
• Raf Souccar (Chairman, Safe Supply) – Emphasized alignment with MAHA mission and frontline opioid‑crisis experience.

Notable Quotes

• Geoff Benic: “By manufacturing domestically with MDBio, we're able to respond quickly and reliably to the needs of communities, universities, non-profits and public agencies already mobilizing under SOR and TOR grants.”
• Raf Souccar: “As someone who has worked on the front lines of the opioid crisis, I see firsthand the value of tools that empower communities to intervene early and save lives.”